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ABSTRACT
UHRF1 is a histone- and DNA-binding E3 ubiq-
uitin ligase that functions with DNMT1 to main-
tain mammalian DNA methylation. UHRF1 facilitates
DNMT1 recruitment to replicating chromatin through
a coordinated mechanism involving histone and
DNA recognition and histone ubiquitination. UHRF2
shares structural homology with UHRF1, but sur-
prisingly lacks functional redundancy to facilitate
DNA methylation maintenance. Molecular mecha-
nisms uncoupling UHRF2 from DNA methylation
maintenance are poorly defined. Through compre-
hensive and comparative biochemical analysis of re-
combinant human UHRF1 and UHRF2 reader and
writer activities, we reveal conserved modes of hi-
stone PTM recognition but divergent DNA binding
properties. While UHRF1 and UHRF2 diverge in their
affinities toward hemi-methylated DNA, we surpris-
ingly show that both hemi-methylated and hemi-
hydroxymethylated DNA oligonucleotides stimulate
UHRF2 ubiquitin ligase activity toward histone H3
peptide substrates. This is the first example of an
E3 ligase allosterically regulated by DNA hydrox-
ymethylation. However, UHRF2 is not a productive
histone E3 ligase toward purified mononucleosomes,
suggesting UHRF2 has an intra-domain architecture
distinct from UHRF1 that is conformationally con-
strained when bound to chromatin. Collectively, our
studies reveal that uncoupling of UHRF2 from the
DNA methylation maintenance program is linked to
differences in the molecular readout of chromatin
signatures that connect UHRF1 to ubiquitination of
histone H3.
INTRODUCTION
Amajor challenge ofmodern biology has been to determine
how DNA-templated processes like transcription, replica-
tion and repair are temporally and spatially regulated in the
context of chromatin. Histone post-translational modifica-
tions (PTMs) and DNA methylation have emerged as key
regulators of chromatin accessibility, interaction, and sig-
naling. Breakthroughs in our understanding of chromatin
regulatorymechanisms have beenmade through the charac-
terization of protein machineries that write, erase, and read
these epigenetic marks. The faithful mitotic inheritance of
DNA methylation patterns is essential for mammalian de-
velopment and is well studied for its key roles in the sta-
ble transcriptional silencing of genes and transposable el-
ements, genomic imprinting, and X-chromosome inactiva-
tion (1). DNA methylation patterns are established by de
novo methyltransferases during early embryonic develop-
ment and are maintained through somatic cell divisions by
themaintenancemethyltransferaseDNMT1 (DNAmethyl-
transferase 1), which has increased catalytic activity toward
hemi-methylated DNA (He5mC) (2–4). The E3 ubiquitin
ligase UHRF1 (ubiquitin-like, containing PHD and RING
finger domains 1) is now appreciated as a key regulator
of DNMT1-mediated DNA methylation maintenance. Ge-
netic and biochemical studies revealed that UHRF1 plays
a central role in DNMT1-directed DNAmethylation main-
tenance during DNA replication (5,6). Deletion of Uhrf1
(or Np95) in mice is embryonic lethal, and stem cells de-
rived from Uhrf1−/− embryos (and also from human cells
depleted of UHRF1) show a dramatic loss in DNA methy-
lation, impaired maintenance of higher-order chromatin
structure, and spurious transcription of otherwise silenced
repetitive DNA elements (6–9).
The DNAmethylation maintenance function of UHRF1
is dependent on its ability to bind chromatin, where it fa-
cilitates ubiquitination of histone H3 at lysines 18 and 23
(H3K18ub and H3K23ub, respectively), a proposed dock-
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ing site for DNMT1 (10–13). UHRF1 has three domains
that directly bind chromatin. The SRA (SET and RING-
associated) domain of UHRF1 is a DNA-binding domain
that recognizes 5-methylcytosine (5mC) in the context of
hemi-methylated double-stranded CpG dinucleotides (14–
16). UHRF1 also binds the unmodified N-terminus of hi-
stone H3 through a plant homeodomain (PHD) finger
(17,18) and di- and tri-methylated lysine 9 on histone H3
(H3K9me2/me3) through an aromatic cage in the first sub-
domain of its tandem Tudor (19,20). Our studies showed
that multivalent recognition of histone H3 by the UHRF1
TTD-PHD is required for its DNA methylation mainte-
nance function in human cancer cells (21). We and oth-
ers also defined a positive allosteric relationship between
the histone- and DNA-binding activities of UHRF1 and
showed that SRA binding to He5mC allosterically activates
its ubiquitin ligase activity toward histone substrates (22–
24).
The UHRF protein family has at least two bona fide
members (25). UHRF2 is an E3 ubiquitin ligase that is
also capable of SUMOylating proteins (26,27). However,
there are few known substrates of UHRF2′s ubiquitin and
SUMO ligase activities (28). UHRF2 is highly homologous
to UHRF1 in sequence and structure (Supplementary Fig-
ure S1), but it does not appear to be functionally redun-
dant in the maintenance of DNA methylation (22,29,30).
The inability of UHRF2 to functionally compensate for
UHRF1 is further demonstrated by the reduction of 5mC in
Uhrf1-null mESCs, despite similar levels ofUhrf1 andUhrf2
transcripts (DBTMEE, (31)). Recent studies reported that
UHRF2 is a reader of 5hmC (32,33) and is required to
maintain 5hmC levels in the brains of mice (34,35).
Amechanistic explanation for why UHRF2 is uncoupled
from DNA methylation maintenance is lacking. Here, we
compare and contrast the biochemical activities of UHRF1
andUHRF2withmodified histone peptides, DNAoligonu-
cleotides, and purified mononucleosomes. We reveal sim-
ilarities and differences in the reader and writer func-
tions of these proteins. While UHRF1, but not UHRF2,
has enhanced affinity for He5mC over unmodified DNA
(UnDNA), He5mC stimulates the enzymatic activity of
both UHRF proteins toward H3 peptide substrates. Sur-
prisingly, the enzymatic activity of UHRF2, and to a lesser
extent UHRF1, is stimulated by He5hmC, despite its in-
ability to discriminate this mark from UnDNA or symmet-
rically modified (Sy5mC or Sy5hmC) DNA. Notably, we
show that histone peptides, as substrates of UHRF1 and
UHRF2 ubiquitin ligase activity, do not reveal differences
that are apparent when using purified mononucleosomes as
substrates. Our studies are consistent with a report show-
ing that UHRF2 is unable to recruit DNMT1 to replicat-
ing chromatin (29), a finding we now propose is a result
of its inability to ubiquitinate chromatinized histone sub-
strates. Collectively, our studies reveal that the uncoupling
of UHRF2 from the DNA methylation maintenance pro-
gram is linked, at least in part, to differences in the molecu-
lar readout of chromatin signatures that connectUHRF1 to
ubiquitination of histone H3. We suggest that differences in
UHRF protein interactions with chromatin, presumably re-
sulting from distinct intramolecular domain organization,
contribute to a divergence in the writing of nucleosomal hi-
stone ubiquitination.
MATERIALS AND METHODS
Cell culture and plasmids
HeLa were originally purchased from ATCC and main-
tained in Dulbecco’s Modified Eagle Medium (Life Tech-
nologies) supplemented with 10% FBS (Sigma) and 1%
penicillin/streptomycin solution (Thermo), at 37◦C with
5% CO2. For bacterial expression, full length open read-
ing frames of UHRF1 (1–793) and UHRF2 (1–802) were
cloned by Gibson Assembly (NEB) into a modified pQE
vector in frame with an N-terminal 6X histidine–maltose
binding protein-tobacco etch virus cleavage site (6XHis-
MBP-TEV). TTD-PHD (UHRF1: 125–364; UHRF2: 119–
392) domains were cloned into pGEX-4T1 as N-terminal
GST fusions. The expression construct for UBA1 was a gift
from Dr Cynthia Wolberger (Addgene plasmid #34965).
UBCH5A was a gift from Dr Rachel Klevit. The expres-
sion construct for TEV enzyme was a gift from Dr Jiyan
Ma. The pSEB-N3F (N-terminal 3X-FLAG) used in chro-
matin association assays was a gift from Tong-Chuan He.
UHRF2 ORFs were cloned into pSEB-N3F with HindIII
and MluI restriction sites.
Chromatin association assays
HeLa cells were transfected with XtremeGene HP (Roche)
at a 3:1 ratio with plasmid DNA in 60 mm dishes. After 48
h, cells were harvested by scraping into cold 1× PBS pH 7.6,
pelleted at 1000 g for 5 min, and resuspended in 120 l cold
CSK buffer (10 mM PIPES pH 7.0, 300 mM sucrose, 100
mM NaCl, 3 mM MgCl2, 0.1% Triton X-100, protease in-
hibitors (Roche; 1 tablet per 20 ml)). Cells were kept on ice
for 20 min. Total protein was quantified by Bradford Assay
(BioRad), and 10% was combined with an equivalent vol-
ume of cold endonuclease-supplemented CSK (Pierce, 250
units/5 ml). Note that the concentration of the total frac-
tion is now 0.5×. Remaining cell lysates were centrifuged at
1300 g for 5min at 4◦C. The supernatant (soluble fraction)
was collected. The chromatin pellet was washed 1× in CSK
buffer, and pelleted 1300 g for 5min at 4◦C. The supernatant
was discarded and the chromatin pellet was solubilized in
cold endonuclease-supplemented CSK buffer. Five micro-
gram of total protein and volume equivalents of chromatin
and soluble fractions were loaded for western blot analysis.
Recombinant protein production
Bacterial expression constructs were transformed into
BL21(DE3) Escherichia coli and grown at 37◦C in LB
Lennox (Cassion) media in baffled flasks at 160 rpm. When
cells reached an OD600 = 0.8–1.0, the temperature was low-
ered to 16◦C, IPTG was added (0.5 mM), and cultures were
incubated with shaking for 16 h. Bacteria were harvested
by centrifugation and washed 1× with cold PBS pH 7.6.
Pellets were either frozen at –80◦C or resuspended in lysis
buffer (His-tag: 50 mM Tris–HCl pH 8.0, 500 mM NaCl,
20 mM imidazole, 1 mM PMSF and 1 mMDTT; GST-tag:
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1× D-PBS, 1 mM PMSF and 1 mM DTT). Lysis was per-
formed on ice by addition of lysozyme (30 min), followed
by five rounds of sonication (20 s of sonication, followed
by 2 min on ice) at 40% amplitude with a micro-tip (Bran-
son Digital 450). Lysates were cleared by centrifugation at
38 000 g for 30 min at 4◦C. Purification was performed by
batch technique as follows. Cleared lysates were mixed for
1 h at 4◦C with His60 Superflow Resin (Clontech) or glu-
tathione agarose (Pierce), 5ml equilibrated inBufferA (His-
tag: 50mMTris–HCl pH 8.0, 500mMNaCl, 20mM imida-
zole; GST-tag: 1× D-PBS). Resin and bound protein were
washed three times with 20 bed volumes of Buffer A, fol-
lowed by elution in five bed volumes of Buffer B (His-tag:
25 mM HEPES pH 7.5, 100 mM NaCl, 250 mM imida-
zole; GST-tag: 1× D-PBS, 10 mM L-glutathione (Sigma)).
Protein was either concentrated (Amicon Ultra 15, 30K
MWCO) and injected onto a HiLoad 26/600 Superdex 200
(GEHealthcare) size-exclusion column equilibrated in SEC
buffer (25 mMHEPES pH 7.5, 100 mMNaCl, 1 mMDTT)
or dialyzed into TEV cleavage buffer (His-tag: 50 mMTris–
HCl pH 8.0, 1 mM DTT, 0.5 mM EDTA) with recombi-
nant TEV protease (500 nM). Recombinant TEV protease
was purified as described (36). Cleavage of the 6XHis–MBP
tag was performed overnight at 4◦C, and the cleaved protein
was isolated by size-exclusion chromatography. Fractions
were checked for purity by SDS-PAGEandwere pooled and
concentrated.MBP- andGST-fusions were concentrated to
>80 M, and frozen at –80◦C with 20% glycerol. Cleaved
proteins were concentrated to >20 M and snap frozen in
small aliquots without glycerol.
Fluorescence polarization
For histone binding analysis, H3(1–20) peptides function-
alized with N- or C-terminal 5-carboxyfluorescein (FAM)
were synthesized by the High Throughput Peptide Synthe-
sis and Array (HTPSA) Core Facility at UNC Chapel Hill.
H3(1–20) peptides without FAM were used when monitor-
ing the allosteric relationship between histone and DNA
binding. For DNA binding analysis, complementary 12-bp
DNA oligonucleotides with the following sequences [FAM-
5′-CCATGXGCTGAC-3′ and 5′-GTCAGYGCATGG-3′
(UnDNA: X and Y are cytosine, He5mC: X is 5mC and Y
is cytosine, Sy5mC: X and Y are 5mC, He5hmC: X is 5hmC
andY is cytosine, Sy5hmC: X andY are 5hmC)] were resus-
pending in STE buffer (10 mM Tris–HCl pH 8.0, 100 mM
NaCl, 1 mM EDTA). Equimolar amounts of sense and an-
tisense oligos were combined and boiled in a water bath for
10 min, followed by slow cooling to room temperature to
anneal. Oligo hybridization was checked by 20% PAGE fol-
lowed by fluorescent imaging of the FAM-labeled duplex
as well as by SYBR Gold (Thermo) staining of ssDNA.
Oligos containing 5mC were synthesized by Eurofins Ge-
nomics, and those containing 5hmCwere synthesized by the
Keck Oligonucleotide Synthesis Facility (Yale University).
For histone and DNA binding, proteins were characterized
as either MBP- or GST-fusions. Proteins were titrated with
10 nM FAM-ligand in FP assay buffer (25 mM HEPES
pH 7.5, 100 mM NaCl, 0.05% NP-40). For allosteric DNA
binding analysis (Figure 3B), FP assay buffer included 150
mMNaCl. Assays in 25l volumeswere performed at room
temperature using black 384-well plates (Costar). Polariza-
tion (P) was measured on a Synergy Neo fluorescence mi-
croplate reader (Biotek). Fluorescence intensities were con-
verted to anisotropy (A) with the equationA= 2P/3-P. Dis-
sociation constants (Kd) were calculated by nonlinear re-
gression analysis of anisotropy curves using a one-site bind-
ing model with Hill slope in GraphPad Prism. Error is re-
ported as± standard error of the mean (S.E.M.) from tech-
nical triplicate measurements. Presented data is representa-
tive of at least two biological replicates (new protein preps
and DNA probes). We note some variability in measured
binding constants across biological replicates. To control for
this, each comparative DNA binding assay (UnDNA ver-
sus HeDNA versus SyDNA, and UHRF1 versus UHRF2)
was performed in the same 384-well plate at the same time.
The variability that we present is due to both biological and
technical error, and compounded by difficulties in fitting
Kd for low affinity interactions. A complete list of binding
constants and associated errors from FP measurements are
listed in Supplementary Table S3.
Ubiquitination assays
In vitro ubiquitination reactions were performed in 20 l
volumes for 20 min (unless otherwise indicated) at room
temperature in ubiquitin assay buffer (50 mM HEPES pH
7.5, 66 mM NaCl, 8 mM ATP, 2.5 mM MgCl2, 2.5 mM
DTT). For all reactions (except Supplementary Figure S4),
6xHis-MBP tags were cleaved from UHRF1 and UHRF2.
Reactions contained 1.5 ME3, 50 nM E1 UBA1, 667 nM
E2 UBCH5A, 5 M TAMRA-ubiquitin (BioVision), and
13 M H3(1–32)K9me2 (C-terminal biotin), and 6.25 M
12-bp duplex DNA oligo. The DNA oligos used in ubiq-
uitination reactions have the same sequence and modifica-
tions as those used for fluorescence polarization, but were
synthesized without FAM label. For in vitro ubiquitination
of HeLa mononucleosomes, reactions were run in ubiqui-
tin assay buffer containing 1.5 M E3, 50 nM E1 UBA1,
667 nM E2 UBCH5A, 5 M TAMRA-ubiquitin, and 0.5
M HeLa mononucleosomes (Epicypher). In the compar-
ative time course ubiquitination reaction of peptide (1 M)
and nucleosome (0.5 M), moles of H3 were equal, and
He5mC (6.25 M) was only added to the peptide reactions.
Reactions were quenched by the addition of 5× SDS load-
ing buffer (250 mM Tris–HCl pH 6.8, 50% glycerol, 10%
SDS, 6% beta-mercaptoethanol, 0.25% bromophenol blue)
to a final concentration of 1×. Fresh beta-mercaptoethanol
was added to the loading buffer to reduce E1-ub and E2-ub
conjugatesUbiquitinated species were directly imaged in gel
by Cy3 fluorescence (TAMRA-ubiquitin) on an Azure c400
imaging platform.
Nucleosome pulldowns
For in vitro nucleosome pulldowns, 5 l of streptavidin-
coatedmagnetic bead slurry (Pierce) per pulldownwas equi-
librated in pulldown buffer (25 mM HEPES pH 7.5, 100
mMNaCl, 0.5% BSA, 0.1% NP-40). Beads were incubated
with 50 pmoles of H3K9me3-containing recombinant bi-
otinylated nucleosomes (Epicypher) for 30 min at room
temperature. Conjugated beads were washed twice for 5min
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in pulldown buffer. The indicated GST- or MBP-fusions
(500 pmol) were incubated with conjugated beads overnight
at 4◦C. Beads were then washed three times for 5 min in
pulldown buffer. Beads were boiled in 100 l of 1× SDS
loading buffer (50 mM Tris–HCl pH 6.8, 10% glycerol,
2% SDS, 1.2% beta-mercaptoethanol, 0.05% bromophenol
blue), and 10l was loaded onto gels for western blot. Input
lanes were loaded with 1% of the unbound protein fraction.
Histone peptide microarrays
Histone peptide synthesis (UNC HTPSA), fabrication of
the microarray, and protein domain hybridization was per-
formed as previously described (37,38). Briefly, arrays were
blocked for 30 min in cold array hybridization buffer (1×
PBS pH 7.6, 0.1% Tween-20, 5% BSA (OmniPur, Fraction
V)) and GST-tagged proteins (1 M) were hybridized to
the microarray in a humidified chamber overnight at 4◦C.
Bound protein was labeled with -GST primary and Alex-
aFluor 647-conjugated secondary antibodies (Supplemen-
tary Table S1). Microarrays were fluorescently imaged at 20
m resolution on an Innoscan 1100AL microarray scan-
ner (Innopsys). Image processing and data analysis was
performed as previously described with ArrayNinja (39).
For heat map construction, arrays were normalized to each
other by IgG control spots and the brightest peptide was
set equal to 1 (blue). Peptides were then ranked for UHRF1
TTD-PHD from high to low. Each unique peptide feature
(see Supplementary Table S2 for a full list of peptide fea-
tures spotted on the array) was spotted in triplicate two
times per subarray, and values presented are the average of
measured signals for these individual peptide spots.
Western blotting
After separation by SDS-PAGE, proteins were transferred
to 0.45mPVDFmembrane (AmershamHybond P) using
a semi-dry transfer apparatus (Hoefer) for 1.5 h at a con-
stant current of 1 mA/cm2. Membranes were blocked for 1
h at room temperature in blotting buffer (1× PBS pH 7.6,
0.1% Tween-20, 5% BSA). Primary antibodies (Supplemen-
tary Table S1) were hybridized overnight at 4◦C with gentle
agitation in blotting buffer. Membranes were then washed
three times for 5 min in blotting buffer. HRP-conjugated
secondary antibodies (GE Life Sciences) were hybridized
at room temperature for 1 h in blotting buffer. Membranes
were again washed three times for 5 min in blotting buffer
and reacted with ECL Prime (GE Life Sciences). Blots were
exposed to film and developed on a Kodak system.
RESULTS
UHRF1 and UHRF2 TTD-PHD have conserved reader ac-
tivities towards the N-terminus of histone H3
The inability of endogenous UHRF2 to maintain cellular
DNA methylation, in the absence of UHRF1, led us to hy-
pothesize that differences in chromatin recognition and/or
enzymatic activity contribute to a lack of UHRF2 func-
tional redundancy with UHRF1. To test this hypothesis,
we systematically compared and contrasted the reader and
enzymatic activities of these proteins, including appreciated
mechanisms of UHRF1 intramolecular crosstalk through
multivalent histone and DNA engagement (22,23), as well
as allosteric control of enzymatic activity by He5mC (24).
We first used histone peptide microarrays to query, in a
high-throughput and parallel manner, the reader activities
of the linked TTD-PHD domains of UHRF1 and UHRF2.
The arrays displayed a synthetic library of over 250 unique
modified histone peptides harboring single and combina-
tions of PTMs (Supplementary Table S2), derived largely
from mass spectrometry datasets (40–43). UHRF1 and
UHRF2 TTD-PHDpreferentially boundH3 peptides (Fig-
ure 1A and B), and both preferentially bound toH3K9me2-
and H3K9me3-containing peptides (Figure 1B and C).
Consistent with the known interaction of theUHRF1 PHD
with the freeN-terminus ofH3 (17,18), PTMson the first six
residues of the H3 N-terminus perturbed UHRF1 histone
binding on the arrays (Supplementary Figure S2). UHRF2
binding to arrays appeared less affected by N-terminal H3
PTMs.
To further query the individual TTD and PHD contribu-
tions to histone binding, we next generated predicted loss-
of-function mutations in the UHRF2 TTD-PHD based on
structural alignments with UHRF1 (Supplementary Fig-
ure S3, TTD*: tandem Tudor mutant, PHD*: plant home-
odomain finger mutant). Both the TTD*-PHD and TTD-
PHD* of UHRF1 and UHRF2 were again profiled by hi-
stone peptide microarray. Consistent with the TTD as the
methyl-lysine reading unit (19,20), the TTD*-PHD from
both UHRF1 and UHRF2 exhibited reduced reader ac-
tivity toward H3K9 methylation (Figure 1C–E). Although
subtle, UHRF2 TTD-PHD* maintained some binding to
peptides containing H3K9me2/me3 while UHRF1 TTD-
PHD* did not (Figure 1C and F–G), suggesting the in-
teraction between UHRF2 and H3 may be less dependent
on its PHD finger than UHRF1. Consistently, UHRF2
was more tolerant of asymmetric di-methylation of H3R2
(H3R2me2a) than UHRF1 (Figure 1C and Supplementary
Figure S2B), a PTM known to inhibit H3 binding through
the UHRF1 PHD (44,45).
We next used fluorescence polarization (FP) bind-
ing assays to quantitatively measure interactions be-
tween UHRF1 and UHRF2 TTD-PHD and H3 peptides.
UHRF1 TTD-PHD had a ∼4-fold increase in affinity for
H3(1–20)K9me3 over the unmodified tail (H3(1–20)K9un),
while UHRF2 had a ∼7-fold increase in affinity for
H3(1–20)K9me3 over H3(1–20)K9un (Figure 2A). As pre-
dicted from peptide array experiments, UHRF1 and
UHRF2 TTD mutations demonstrated a lack of selectiv-
ity for H3K9me3 (Figure 2B). Consistent with UHRF1 and
UHRF2 TTD-PHD binding the H3 tail in a multivalent
manner (20,21), PHD mutations, or the addition of an N-
terminal FAM to H3 tail peptides, greatly disrupted mea-
sured interactions of UHRF1 and UHRF2 (Figure 2). FP
binding assays with full-length UHRF1 and UHRF2 ver-
ified that the H3K9me3 reader properties of the isolated
TTD-PHD were conserved in full-length protein (Supple-
mentary Figure S5A). Collectively, these results demon-
strate that UHRF1 and UHRF2 have conserved histone
binding properties through multivalent TTD-PHD engage-
ment of H3K9me2/me3 peptides.
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Figure 1. Functional requirements of histone PTM recognition are conserved between the UHRF1 and UHRF2 TTD-PHD. Scatter plots of normalized
signal intensities from two subarrays hybridized with the indicated wild-type (A, B) and mutant (D–G) TTD-PHD domains of UHRF1 or UHRF2. Each
spot represents average signal from a unique peptide feature (see Supplementary Table S2 for a full list of peptide features spotted on the array) and is
color-coded by histone (A, D, F) or methylation state of H3(1–20)K9 (B, E, G) as described in the key. Peptides are spotted in triplicate two times per
subarray. Raw signal intensities for each peptide spot are normalized to the average IgG control signal on an individual subarray. (C) Heat maps showing
the influence of neighboring PTMs on the indicated wild-type and mutant TTD-PHD interactions with arrayed H3(1–20)K9me3 (top), H3(1–20)K9me2
(middle) or H3(1–20)K9me1 (bottom) peptides.
UHRF1, but not UHRF2, selectively binds He5mC
As the chromatin binding requirements of UHRF1 rely on
both histone and DNA recognition (24), we next sought to
compare the DNA binding properties of these two proteins.
We again used FP binding assays to measure interactions
between full-length UHRF1 and UHRF2 with 12-bp DNA
oligonucleotides harboring a single, centrally-located CpG
that was either unmodified (UnDNA), hemi-methylated
(He5mC), or symmetrically methylated (Sy5mC). UHRF1
displayed a 9- to 32-fold increase (NaCl-dependent) in affin-
ity for He5mC over UnDNA (Figure 3A, B left). However,
UHRF2 had substantially reduced selectivity, in compari-
son to UHRF1, for either He5mC or Sy5mC over UnDNA
(Figure 3A and B, right). We note a 2-fold affinity increase
for He5mC over UnDNA for UHRF2 (Figure 3B, right),
which may represent the error in fitting data without a clear
upper plateau.
We and others previously reported a reciprocal positive
allosteric relationship between the histone and DNA bind-
ing domains of UHRF1 (22–24). Consistent with our pre-
vious results, unlabeled H3(1–20)K9me3 peptides enhanced
the interaction of UHRF1 with both UnDNA and He5mC
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Figure 2. Multivalent histone engagement of UHRF proteins. Fluorescence polarization (FP) binding assays quantifying the interactions between wild-
type (A) and mutant (B, C) TTD-PHD domains of UHRF1 or UHRF2 and the indicated FAM-labeled H3 peptides. Error bars represent s.e.m. from
technical triplicate measurements. n.m., not measurable.
(Figure 3B, left). As observed for UHRF1, UHRF2 also
maintains a positive allosteric relationship between histone
and DNA binding (Figure 3B, right).
Although the reported affinity preference was modest (∼
3-fold preference for Sy5hmC over UnDNA), UHRF2 was
previously reported to read 5hmC (33).We therefore sought
to compare binding of UHRF1 and UHRF2 to 12-bp oli-
gos modified with hemi-hydroxymethylated (He5hmC) and
symmetrically hydroxymethylated (Sy5hmC) DNA (Figure
3C). Neither UHRF1, nor UHRF2, displayed increased
affinity for DNA based on the hydroxymethyl state of a
single CpG dinucleotide in our binding assay. Collectively,
these results revealed thatwhileUHRF1 andUHRF2DNA
binding activities were enhanced by histone engagement,
UHRF2 lacked an increased affinity for He5mC in this se-
quence context. Furthermore, neitherUHRF1 norUHRF2
had a preference for He5hmC or Sy5hmC in this DNA se-
quence context.
UHRF1 and UHRF2 ubiquitin ligase activities are allosteri-
cally activated by hemi-modified DNA
As we previously showed that UHRF1 ubiquitin ligase
activity toward H3 substrates was stimulated by He5mC
oligonucleotides (24), we hypothesized that a lack of selec-
tive binding to He5mC, relative to UHRF1, would com-
promise the ubiquitin ligase activity of UHRF2. To test
this hypothesis, we next performed comparative in vitro
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Figure 3. DNA binding analysis of full length UHRF1 and UHRF2 reveals divergence in He5mC reader activity. (A–C) FP binding assays quantifying
the interactions between full-length UHRF1 (left) or UHRF2 (right) and the indicated FAM-labeled DNA oligonucleotides. For (B), FP measurements
were made in the presence of a saturating concentration (13 M) of H3(1–20)K9me3. Error bars represent S.E.M. from technical triplicate measurements
(A, B: 150 mM NaCl; C: 100 mM NaCl).
ubiquitination reactions for UHRF1 and UHRF2 with
H3(1–32)K9me2 peptide substrates in the absence or presence
of saturating concentrations of modified DNA oligonu-
cleotides (Figure 4A). Consistent with previous results,
UHRF1 activity toward histone substrates and toward it-
self (auto-ubiquitination) was stimulated by He5mC. Sur-
prisingly, UHRF2 enzymatic activity was also stimulated by
He5mC, despite having substantially reduced selectivity for
this mark over UnDNA, relative to UHRF1 (Figure 3A,
B, and Figure 4A). In addition, He5hmC, but not Sy5hmC
stimulated the enzymatic activity ofUHRF2, and to a lesser
extent UHRF1.
We next performed a time-course analysis of hemi-
modified DNA activation of UHRF1 and UHRF2 ligase
activities. UHRF1 and UHRF2 were indistinguishable in
their ability to ubiquitinate themselves and H3(1–32)K9me2
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Figure 4. UHRF1 and UHRF2 E3 ligase activities are allosterically activated by hemi-modified DNA toward histone substrates. (A) In vitro ubiquiti-
nation of H3(1–32)K9me2 by UHRF1 (left) or UHRF2 (right) in the absence or presence of a saturating concentration (6.25 M) of the indicated DNA
oligonucleotides. Time course in vitro ubiquitination of H3(1–32)K9me2 by UHRF1 (left) or UHRF2 (right) in the presence of a saturating concentration
(6.25 M) of He5mC (B) or He5hmC (C).
peptide substrates in the presence of He5mC (Figure 4B).
However, UHRF2 (but not UHRF1) enzymatic activity to-
ward H3(1–32)K9me2 peptide substrates was rapidly stimu-
lated in the presence ofHe5hmCdespite a lack of preference
toward this mark for either protein (Figure 4C and Figure
3C). We note that the N-terminal MBP-tag slows the ki-
netics of the UHRF2 ubiquitination reaction (Supplemen-
tary Figure S4A), and we took advantage of this to capture
the dynamics of He5hmC-stimulated UHRF2 ubiquitina-
tion (Supplementary Figure S4B, left). Introducing a loss-
of-function mutation in the UHRF2 SRA (Supplementary
Figure S3) disruptedHe5hmC-dependent ubiquitin activity
toward H3(1–32)K9me2 peptide substrates (Supplementary
Figure S4B). Collectively, these results demonstrated that
UHRF1 and UHRF2 ubiquitin ligase activity is stimulated
by He5mC, and that UHRF2 (but not UHRF1) activity is
robustly stimulated by He5hmC and its interaction with the
SRA domain. This is, to our knowledge, the first example
of an E3 ubiquitin ligase allosterically regulated by DNA
hydroxymethylation. Importantly, these results suggest that
hemi-modified DNAs allosterically activate E3 ligase ac-
tivity towards peptide substrates through a conformational
change in UHRF proteins that is not discernable through
FP binding measures.
UHRF2 ubiquitin ligase activity towards histones is restricted
by chromatin
To evaluate how mutations in UHRF2 chromatin read-
ing domains (TTD*, PHD*, and SRA*: G477D, Supple-
mentary Figure S3) affected chromatin binding in cells,
we performed chromatin association assays with FLAG-
tagged UHRF2 (Figure 5A). In a behavior shared with
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Figure 5. UHRF1 and UHRF2 diverge in their ability to ubiquitinate nucleosomal histones. (A) Chromatin association assays for FLAG-tagged UHRF2
(WT) or the indicated mutants from asynchronously growing HeLa cells. Mock treatment represents an empty vector control. (B) Comparative in vitro
ubiquitination of H3(1–32)K9me2 (left) and HeLa mononucleosomes (right) by UHRF1 and UHRF2. Moles of H3 are equivalent in these reactions.
UHRF1 (24), mutation of either histone- or DNA-binding
domains reduced the amount of chromatin-bound UHRF2
in HeLa extracts. We next sought to compare E3 ligase ac-
tivities of UHRF1 and UHRF2 on physiologic chromatin
substrates using purified HeLa mononucleosome prepa-
rations. Surprisingly, UHRF2 was unable to ubiquitinate
histones in the context of nucleosomes (Figure 5B, Sup-
plementary Figure S5B). Auto-ubiquitination of UHRF2
in these assays confirmed the enzyme was active. We also
performed a comparative ubiquitination reaction between
UHRF1 and UHRF2 with both peptides and mononucle-
osomes where H3(1–32)K9me2 was in two-fold molar ex-
cess over mononucleosomes to maintain equivalent moles
of H3 (Figure 5B). Consistent with our initial findings (Fig-
ure 4B), UHRF1 and UHRF2 ubiquitin ligase activities to-
wardH3(1–32)K9me2 peptide substrates were similar (Figure
5B, left), but the activity difference toward histones was re-
vealed when queried on nucleosomal substrates (Figure 5B,
right). A possible explanation for the differences between
UHRF1 andUHRF2 ligase activity in these assays was that
UHRF2 binding to nucleosomes was weaker thanUHRF1.
However, pulldown assays would suggest the contrary, as
more UHRF2 (TTD-PHD and full-length) pulled down
with recombinant unmodified and H3K9me3-containing
mononucleosomes than UHRF1 (Supplementary Figure
S5C). Collectively, these findings show that while histone
and DNA binding is required to target UHRF2 to bulk
chromatin in cells, the assembly of UHRF2 on chromatin is
likely distinct from UHRF1, resulting in a geometry unfa-
vorable for histone ubiquitination. Consistent with this hy-
pothesis, we were unable to stimulate UHRF2 enzymatic
activity toward nucleosomal histone substrates by swap-
ping the UHRF2 SRA with that of UHRF1 (Supplemen-
tary Figure S5B). Notably, a TTD-SRA swap was also not
active as a nucleosomal histone E3 ligase, suggesting re-
gions outside the chromatin binding unit also contribute
to positioning UHRF1 in a conformation productive for
nucleosomal histone ubiquitination. Both chimeric proteins
retained auto-ubiquitination. As ubiquitination of H3K18
and H3K23 is required for the binding of DNMT1 to chro-
matin (13), our studies reveal a key biochemical difference
between UHRF1 and UHRF2, at the level of nucleosomal
histone ubiquitination, that restricts the ability of UHRF2
to functionally complement for UHRF1 as a regulator of
DNA methylation maintenance.
DISCUSSION
Here we present a comprehensive biochemical comparison
between two highly conserved E3 ubiquitin ligases, UHRF1
and UHRF2, and we reveal similarities and differences in
chromatin recognition through histone and DNA binding,
as well E3 ligase activities (summarized in Supplementary
Table S4). This study sheds light on how multivalent chro-
matin engagement controls the enzymatic activity ofUHRF
proteins. We demonstrate that on H3 peptides, UHRF1
and UHRF2 E3 ligase activities are indistinguishably ac-
tivated by He5mC. However, UHRF2 E3 ligase activity is
robustly activated by He5hmC, while UHRF1 is not. This
is, to our knowledge, the first allosteric function identified
for 5hmC and suggests UHRF2 may play a role in the reg-
ulation and/or maintenance of this mark. Consistent with
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this hypothesis, the enzymatic activity of TET2 was shown
to be stimulated by UHRF2, and knockdown of UHRF2
resulted in accumulation of 5mC (30,32).
On nucleosome substrates, UHRF1 actively ubiquiti-
nates histones, while UHRF2 does not. Our data show that
the enzymatic differences between UHRF1 and UHRF2
are not due to histone substrate binding affinity differences
(Supplementary Figure S5A, C). Rather, we suggest that
when UHRF1 and UHRF2 engage histones and DNA in
the context of a nucleosome, they adopt unique superter-
tiary structures (46). UHRF2 is constrained in a conforma-
tion that is incompatible with enzymatic activity toward hi-
stones, while UHRF1 is in a productive conformation. As
UHRF2 is unable to deposit H3 ubiquitination, a proposed
recruitmentmechanism forDNMT1,UHRF2 is uncoupled
from the maintenance of DNA methylation and unable to
functionally compensate for UHRF1.
Our histone peptide microarray experiments revealed
many subtle differences between UHRF1 and UHRF2 hi-
stone recognition, suggesting these H3 binding units may
not be completely conserved in their mode of recognition.
For peptides containing H3K9me2/me3, H3R2me2a and
H3K4ac was tolerated by UHRF2, but not by UHRF1,
while H3K4me3 was tolerated by UHRF1 but not for
UHRF2 (Figure 1C). The differing influence of N-terminal
modifications on UHRF1 and UHRF2 histone recogni-
tion suggests differences in the PHD domain and its in-
teraction with the N-terminus of H3 (Supplementary Fig-
ure S2A, B). Indeed, in-cell validation of UHRF2 histone
binding revealed that less UHRF2 was bound to chro-
matin with a loss-of-function mutation in the TTD than the
PHD (Figure 5A). Interestingly, after filtering the microar-
ray results for singly modified H3(1–20) peptides, we found
that UHRF1 top hits included H3R8me1, H3R8me2s,
H3K9me2, H3K18me3, and H3K14me3 (Supplementary
Figure S2). The top hits for UHRF1 have not all been re-
ported, and may represent new marks read by UHRF1.
In contrast, UHRF2 top hits were clearly H3K9me3 and
H3K9me2. Although we did not measure tighter binding
for UHRF2 with H3 peptides than UHRF1 by FP (Fig-
ure 2A), this may be due to differences in the experimental
setup of each assay. For FP assays, H3 tail peptides are in
solution and free of any steric hindrance that may be pro-
vided by the nucleosome core particle or DNA. The mi-
croarray presents peptides immobilized on glass and may
bemore sterically representative of a histone tail protruding
from the nucleosome core particle. Collectively, these data
support that UHRF2 interaction with histones is more re-
liant on the TTDdomain than the PHDdomain. Compara-
tive structural analysis of UHRF1 andUHRF2 TTD-PHD
is likely to reveal subtle differences in the organization of
these linked histone binding modules (there is no structure
of UHRF2 TTD-PHD bound to H3).
UHRF1 and UHRF2 are the only mammalian proteins
with an SRA domain. SRA domains have been exten-
sively characterized as DNA binding domains in plants,
and structural studies of SRA domains and various DNA
probes consistently revealed a base flipped out of the DNA
helix into a hydrophobic pocket of the SRA (14–16,47).
To compare the DNA binding properties of UHRF1 and
UHRF2, we first generated a mutation in the SRA do-
main of UHRF2 (SRA*: G477D) by introducing a neg-
atively charged aspartic acid where the DNA backbone
contacts the SRA domain (Supplementary Figure S3).
The UHRF2 SRA* was informed by structural alignment
with the UHRF1 SRA, and generation of the homolo-
gous UHRF1G448Dmutant known to disrupt DNAbind-
ing (24,48). We found that in addition to histone bind-
ing, DNA binding was required for UHRF2 chromatin
association (Figure 5A). The co-requisites of histone and
DNA binding for chromatin association revealed the multi-
valent nature of UHRF2, a behavior shared with UHRF1
(20,21,24). To comparatively evaluate the DNA binding
properties of UHRF1 andUHRF2, we performed FP bind-
ing assays with modified DNA. UHRF1 demonstrated
increased affinity toward He5mC DNA over UnDNA,
whereas UHRF2 had minimal preference for methylated
DNA of any state (Figure 3). In a behavior that is shared
with UHRF1, the presence of H3K9me3 peptide increased
affinity for DNA as measured by FP (Figure 3B). Although
this positive allosteric mechanism is not structurally under-
stood, we and others previously reported an interaction be-
tween the UHRF1 TTD-PHD and SRA-RING, and this
interaction was modulated by DNA binding (23,24). It is
important to note that this behavior was generally described
for DNA, regardless of the methylation status. Understand-
ing the coordinated binding of histone and DNA, for both
UHRF1 and UHRF2, will require structural knowledge of
the intra-domain organization of these proteins.
Existing data supporting UHRF proteins as specific
readers of 5hmC is inconsistent (32,33,49). Crystal struc-
tures of the SRA domain of UHRF2 with He5mC and
He5hmC have been solved, despite lacking increased affin-
ity for either DNA probe over UnDNA, as measured by FP
(33). To clarify whether UHRF1 or UHRF2 were readers
of 5hmC, we measured binding to He5hmC and Sy5hmC
DNA probes (Figure 3C). Neither UHRF1 nor UHRF2
showed increased affinity for 5hmC in either context by FP.
Possible explanations for differences in our binding mea-
sures compared to others could be the composition of the
DNA probe and the salt concentration used. Our probe is
12-bp in length with a single, centrally located CpG. Other
studies have used longer probes with multiple 5hmC CpGs
to enrich for UHRF2 (32). Measuring interactions with
longer DNA probes with multiple 5hmC sites may reveal
differences in stoichiometry rather than differences in affin-
ity. Previous studies demonstrated salt concentration as a
critical regulator of DNA binding constants (23,24), where
lower salt resulted in tighter binding to DNA for UHRF1.
We used both 100 mM and 150 mM NaCl for binding as-
says in this study, which must be considered when compar-
ing our results to others. It is also possible that structural
studies and binding assays with isolated domains do not ac-
curately reflect the full-length protein behavior, as has been
shown here for histone binding (Figure 2A and Supplemen-
tary Figure S5A), as well as by others for DNA binding
(23,24).
Comparative ubiquitination assays for UHRF1 and
UHRF2 were surprising in many ways. The first surprise
was that both He5mC and He5hmCDNA probes activated
the E3 ligase activity ofUHRF1 towardH3K9me2 peptides
(Figure 4A), although to a lesser degree for He5hmC. We
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previously attributed the allosteric activation of UHRF1
by He5mC, at least in part, to an increased affinity for
He5mC DNA (24). However, the activation of UHRF2 by
He5mC and He5hmC is independent of increased affinity
over UnDNA (Figures 3 and 4). The activation of UHRF1
and UHRF2 by any DNA that is hemi-modified suggests
a conformational activation conditional upon binding of
asymmetricallymodifiedCpGdinucleotides (Figure 4). Our
data introduce a new paradigm to the field. In the strict
definition of mark discrimination through affinity mea-
surements, we would not call the UHRF2 SRA domain a
5hmC reader. However, UHRF2 is clearly ‘reading’ 5hmC-
modified DNA in a unique way that results in allosteric ac-
tivation of its E3 ligase activity. We propose that the def-
inition of an epigenetic ‘reader’ be refined to not only in-
clude proteins that measure increased affinity for a specific
modification state, but also for proteins whose enzymatic
activity is modulated by the mark they are reading. Fu-
ture studies are needed to understand themolecular basis of
hemi-modified DNA-dependent activation of UHRF1 and
UHRF2 E3 ligase activity.
As histone peptides and DNA probes are not physically
linked as they would be presented in a nucleosome, they
represent a trans model. The trans nature of our ubiquiti-
nation assays provided no conformational restraint to the
geometries of UHRF1 and UHRF2, and resulted in no
significant differences in E3 ligase activity by He5mC ac-
tivation. By performing ubiquitination reactions on puri-
fied mononucleosomes, we introduced physical constraints
to UHRF1 and UHRF2, with histone and DNA presented
in a cis fashion (Figure 5B and Supplementary Figure S5B).
With conformational constraint imposed on UHRF1 and
UHRF2 by engagement of the nucleosome, only UHRF1
was a productive E3 ligase. These data support a hypothe-
sis that intramolecular geometries of UHRF1 andUHRF2,
as conferred by divergence of their intra-domain architec-
ture, are key differences that govern allosteric control of E3
ligase activity. Alternatively, differences in He5mC specifici-
ties between UHRF1 and UHRF2 may be borne out in the
context of the nucleosome that are otherwise missed study-
ing activities with free peptides and DNA oligonucleotides.
Future studies evaluating the interactions and activities of
UHRF1 andUHRF2with nucleosomes will reveal molecu-
lar details regulating the divergent substrate specificities of
these two enigmatic proteins.
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